We are live on ! Find out more
SAMH

Shanda Asset Management Holdings Portfolio holdings

AUM $1.85B
1-Year Est. Return 36.09%
This Fund
S&P 500
This Quarter Est. Return
-26.31%
1 Year Est. Return
+36.09%
3 Year Est. Return
+114.94%
5 Year Est. Return
-33.67%
10 Year Est. Return
-25.97%
AUM
$652M
AUM Growth
-$98.7M
Cap. Flow
+$130M
Cap. Flow %
19.9%
Top 10 Hldgs %
92.21%
Holding
53
New
14
Increased
5
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$137M
2
GE icon
GE Aerospace
GE
+$39.8M
3
ACHC icon
Acadia Healthcare
ACHC
+$3.36M
4
KN icon
Knowles
KN
+$3.34M
5
TDOC icon
Teladoc Health
TDOC
+$3.32M

Sector Composition

Rank Sector Weight
1 Financials 61.2%
2 Healthcare 18.93%
3 Industrials 7.91%
4 Energy 3.95%
5 Communication Services 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
26
Wayfair
W
$11.8B
$1.2M 0.18%
+15,000
New +$1.05M
FNGN
27
DELISTED
Financial Engines, Inc.
FNGN
$1.14M 0.17%
+37,543
New +$1.18M
CTRA
28
DELISTED
Coterra Energy
CTRA
$1.07M 0.16%
37,416
RRC icon
29
Range Resources
RRC
$9.43B
$988K 0.15%
57,920
DPZ icon
30
Domino's
DPZ
$12.1B
$945K 0.15%
+5,000
New +$926K
FNSR
31
DELISTED
Finisar Corp
FNSR
$916K 0.14%
45,000
PDCE
32
DELISTED
PDC Energy, Inc.
PDCE
$868K 0.13%
16,839
NBIX icon
33
Neurocrine Biosciences
NBIX
$16.9B
$776K 0.12%
10,000
VNDA icon
34
Vanda Pharmaceuticals
VNDA
$315M
$681K 0.1%
+44,787
New +$665K
SFM icon
35
Sprouts Farmers Market
SFM
$8.28B
$675K 0.1%
+27,716
New +$587K
TVRD
36
Tvardi Therapeutics
TVRD
$19M
$673K 0.1%
+1,527
New +$696K
ACOR
37
DELISTED
Acorda Therapeutics
ACOR
$557K 0.09%
216
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$511K 0.08%
+35,278
New +$545K
PTCT icon
39
PTC Therapeutics
PTCT
$5.68B
$506K 0.08%
+30,332
New +$513K
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$401K 0.06%
10,000
SUPN icon
41
Supernus Pharmaceuticals
SUPN
$2.67B
$399K 0.06%
10,000
WLL
42
DELISTED
Whiting Petroleum Corporation
WLL
$331K 0.05%
167
AXSM icon
43
Axsome Therapeutics
AXSM
$10.9B
$112K 0.02%
+19,958
New +$101K
MRNS
44
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$82K 0.01%
2,500
PTX
45
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$2K ﹤0.01%
1,000
AMBA icon
46
Ambarella
AMBA
$3.63B
-10,000
Closed -$490K
BHC icon
47
Bausch Health
BHC
$2.62B
-700,000
Closed -$10M
MAT icon
48
Mattel
MAT
$4.32B
-1,700,000
Closed -$26.3M
PLNT icon
49
Planet Fitness
PLNT
$4.45B
-80,000
Closed -$2.16M
WT icon
50
WisdomTree
WT
$3.21B
-1,253,659
Closed -$12.8M

Similar funds

Shanda Asset Management Holdings's Q4 2017 Portfolio in Review

As of Q4 2017, Shanda Asset Management Holdings held 53 positions worth $652M, down 13% from $750M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Shanda Asset Management Holdings deployed $130M of net new capital in Q4 2017, opening 14 new positions and adding to 5 existing holdings. Its largest new stake was Acadia Healthcare: 96,957 shares worth $3.16M.

By sector, the portfolio is most concentrated in Financials at 61% of assets, up from 56% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was KKR & Co, an estimated $4.02M trimmed.

  • Shanda Asset Management Holdings's largest Q4 2017 buy was Acadia Healthcare: 96,957 shares worth $3.16M.
  • Shanda Asset Management Holdings added most to Happen Inc in Q4 2017, an estimated $137M increase.
  • Shanda Asset Management Holdings's biggest Q4 2017 reduction was KKR & Co, cutting an estimated $4.02M.
  • Shanda Asset Management Holdings fully exited Mattel in Q4 2017, selling an estimated $26.3M.
  • Shanda Asset Management Holdings's ten largest holdings make up 92% of its $652M portfolio in Q4 2017.
  • Shanda Asset Management Holdings opened 14 new positions and closed 8 in Q4 2017.
  • Shanda Asset Management Holdings's portfolio value fell 13% quarter-over-quarter to $652M.

Based on Shanda Asset Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.